Free from harsh irritants
It represents a new generation of GLP-1 therapies that move beyond injectable peptides to offer patients an oral pill option with competitive weight loss efficacy
Glucagon-like peptide-1 receptor (GLP-1R) is a member of the glucagon-like receptor subfamily of the G protein-coupled receptor B family and is widely expressed in the cardiovascular system, brain, hypothalamus, hippocampus, kidney, liver, lung, digestive tract, pancreas, fat and skeletal muscle ( Due to the wide distribution of GLP-1R, the pharmacological effects of GLP-1RA after interaction with receptors are also extremely extensive
Over time, this can leave eggs and the uterine lining under-supported, even when body weight changes in the intended direction and standard blood tests remain within range
Drescher M, Marcotte S, Grant R, et al